Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ondansetron versus pyridoxine for morning sickness in pregnancy: neonatal outcomes
IRCT2015082523749N1Phase 2Completed
- Sponsor
- Zabol University of Medical Sciences
- Start
- Jun 2014
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2 trial of ondansetron and pyridoxine in nausea and vomiting of pregnancy (NVP) (2 arms), sponsored by Zabol University of Medical Sciences. Primary endpoint: Neonatal outcome. Started Jun 2014; status: completed.
02
Drugs
ondansetronpyridoxine
03
Conditions
nausea and vomiting of pregnancy (NVP)
Beyond the preview
Go deeper on IRCT2015082523749N1.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT2015082523749N1.